(Q34796431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

High-dose methylprednisolone for acute closed spinal cord injury--only a treatment option (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

H Hugenholtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D E Cass

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M F Dvorak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D H Fewer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R J Fox

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D M S Izukawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Lexchin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Tuli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

N Bharatwal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Short

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

227-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Methylprednisolone and acute spinal cord injury: an update of the randomized evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

[Medical treatment of spinal cord injury in the acute stage]

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

The John Stanley Coulter Lecture. Predicting recovery after spinal cord injury: a rehabilitation imperative.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

The two-edged sword of large-dose steroids for spinal cord trauma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Application of dexamethasone in the treatment of acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Risk of avascular necrosis following short term megadose methylprednisolone treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Consequences of high-dose steroid therapy for acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

The role of steroids in acute spinal cord injury: an evidence-based analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Gastrointestinal bleeding in patients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Massive steroids do not reduce the zone of injury after penetrating spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Recovery of ambulation in motor-incomplete tetraplegia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Spinal cord injury outcomes in a population-based sample

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Pharmacological therapy of spinal cord injury during the acute phase

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Use of steroids for acute spinal cord injury must be reassessed

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Use of methylprednisolone as an adjunct in the management of patients with penetrating spinal cord injury: outcome analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

An evaluation of the factors affecting neurological recovery following spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001992

7 January 2021

10.1017/S0317167100001992

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12195611%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference